Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

The interaction between the brain and the vascular system could hold the key to lowering disease risk. According to the ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread ...

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

The study supports prior research that found the same thing.

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

Alzheimer’s blood tests are the key to widespread prevention of dementia, experts say. If people can be diagnosed in their doctor’s office, they can more immediately move into preventive care ...